IDXX Stock IDXX is expected to report earnings to rise+16.38% to $2.7 per share on May 01

A.I.dvisor
at Tickeron.com
04/30/24
Loading...
IDXX - IDEXX Laboratories
IDEXX Laboratories Earnings Graph
Q1'24
Est.
$2.70
Q4'23
Beat
by $0.20
Q3'23
Beat
by $0.16
Q2'23
Beat
by $0.22
Q1'23
Beat
by $0.12
The last earnings report on December 31 showed earnings per share of $2.32, beating the estimate of $2.12. P/B Ratio (29.762) is normal, around the industry mean (22.483). P/E Ratio (52.873) is within average values for comparable stocks, (82.064). Projected Growth (PEG Ratio) (5.079) is also within normal values, averaging (5.589). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (12.195) is also within normal values, averaging (51.692). With 414.11K shares outstanding, the current market capitalization sits at 44.84B.
View a ticker or compare two or three
IDXXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of animal health products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One IDEXX Drive
Phone
+1 207 556-0300
Employees
11000
Web
https://www.idexx.com